Table I.
Reference # Multiple analyses.1 and .2 | M | Endpoint | Lead Author |
---|---|---|---|
13 | 27 | Suicide ideation/Attempt | Bridge (2007) |
14 | 63 | Antibiotic-Associated Diarrhea | Hempel (2012) |
15 | 15 | Risk of Low Birth Weight | Kayentao (2013) |
16 | 15 | Venous Thromboembolism | Nalluri (2008) |
17.1 | 8 | Lung Injury | Neto (2012) |
17.2 | 9 | Mortality | Neto (2012) |
18.1 | 8 | Cardiovascular Deaths | Nguyen (2011) |
18.2 | 11 | Prostate Cancer-Specific Mortality | Nguyen (2011) |
19.1 | 21 | Incident Pancreatitis in 21 Large Statin Trials | Preiss (2012) |
19.2 | 7 | Incident Pancreatitis in 7 Large Fibrate Trials | Preiss (2012) |
20 | 16 | Fatal Adverse Events | Ranpura (2011) |
21 | 17 | All-Cause Mortality | Rizos (2012) |
22.1 | 17 | Major Cardiovascular Events-Inhaled Anticholinergics | Singh (2008) |
22.2 | 5 | Major Cardiovascular Events Long term Inhaled Anticholinergics | Singh (2008) |
23.1 | 5 | Major Cardiovascular Events | Udell (2013) |
23.2 | 5 | Cardiovascular Mortality | Udell (2013) |
24 | 25 | In Hospital Mortality | Wiener (2008) |
25 | 35 | Mortality | Zarychanski (2013) |
M=Number of Studies in Analysis
Studies where DL and SGS differ substantially are highlighted.